Delivery Order SPE2DB20D1100-SPE2DB25FE1NK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a pharmaceutical pain management product, with a contract value of $4,001.46. This non-competitive delivery order, issued on August 12, 2025, utilizes firm fixed pricing and is set to conclude on August 13, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single...
- The Defense Logistics Agency awarded a $1,225.04 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg on August 13, 2025, with ultimate completion by August 14, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery under AmerisourceBergen's broader relationship with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.57 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $2,451.24. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Nucynta 50 mg tablets (100 units) with a ceiling value of $1,225.04. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by September 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Nucynta 50 mg tablets (100-count units) with a ceiling value of $1,837.56. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of September 25, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Nucynta 100 mg tablets (100 count) with a ceiling value of $1,908.18. The contract, awarded on September 17, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a...
- The Defense Logistics Agency awarded a $1,371.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta 50 mg tablets (100 count). This is a non-set-aside competitive award with an ultimate completion date of August 21, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta 50 mg tablets (100 count) valued at $1,545.54. This firm fixed-price delivery order is set to be completed by September 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $1,788.38 to AmerisourceBergen Drug Corp for Nucynta 100 mg tablets (100 count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed price pricing and represents a relatively small-value transaction within the pharmaceutical supply...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1NKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,933.54 to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta 100 mg tablets (100 count). The contract, which is a child award under a larger indefinite delivery vehicle, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems globally. The Nucynta order fulfills Defense Logistics Agency medical supply requirements, consistent with the contractor's extensive delivery of brand-name and generic pharmaceuticals across multiple therapeutic domains through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/29/25 |